Aigen Investment Management, LP Supernus Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.09 - $37.88 $197,203 - $240,272	6,343 New	6,343 $226,000
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $308,493 - $449,842	-17,429 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$20.2 - $25.05 $93,182 - $115,555	4,613 Added 35.99%	17,429 $363,000
Q2 2020 Aug 10, 2020	BUY	$17.09 - $24.89 $219,025 - $318,990	12,816 New	12,816 $304,000
Q1 2020 May 08, 2020	SELL	$14.45 - $24.69 $104,227 - $178,088	-7,213 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$19.93 - $29.13 $143,755 - $210,114	7,213 New	7,213 $171,000

279

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.01B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.